|
π
|
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
37 auth.
E. Castro,
C. Goh,
D. Olmos,
E. Saunders,
D. Leongamornlert,
M. Tymrakiewicz,
N. Mahmud,
Tokhir Dadaev,
K. Govindasami,
M. Guy,
E. Sawyer,
R. Wilkinson,
A. Ardern-jones,
Steve Ellis,
D. Frost,
...
S. Peock,
D. Evans,
M. Tischkowitz,
T. Cole,
R. Davidson,
D. Eccles,
C. Brewer,
F. Douglas,
M. Porteous,
A. Donaldson,
H. Dorkins,
L. Izatt,
J. Cook,
S. Hodgson,
M. J. Kennedy,
L. Side,
J. Eason,
A. Murray,
A. Antoniou,
D. Easton,
Z. Kote-Jarai,
R. Eeles
|
9 |
2013 |
9
π
|
|
π
|
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
19 auth.
Z. Kote-Jarai,
D. Leongamornlert,
E. Saunders,
M. Tymrakiewicz,
E. Castro,
N. Mahmud,
M. Guy,
S. Edwards,
S. Edwards,
L. O'Brien,
...
E. Sawyer,
A. Hall,
R. Wilkinson,
Tokhir Dadaev,
C. Goh,
D. Easton,
D. Goldgar,
R. Eeles,
R. Eeles
|
8 |
2011 |
8
π
|
|
π
|
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
131 auth.
Z. Kote-Jarai,
A. Olama,
Graham G. Giles,
G. Severi,
J. Schleutker,
Maren Weischer,
D. Campa,
E. Riboli,
T. Key,
H. Gronberg,
D. J. Hunter,
P. Kraft,
M. Thun,
S. Ingles,
S. Chanock,
...
D. Albanes,
R. B. Hayes,
D. E. Neal,
F. Hamdy,
J. Donovan,
P. Pharoah,
F. Schumacher,
B. E. Henderson,
J. Stanford,
E. Ostrander,
K. D. SΓΈrensen,
T. DΓΆrk,
G. Andriole,
Joanne L Dickinson,
C. Cybulski,
J. LubiΕski,
A. Spurdle,
Judith A. Clements,
S. Chambers,
J. Aitken,
R. A. Gardiner,
S. Thibodeau,
D. Schaid,
Esther M. John,
C. Maier,
W. Vogel,
Kathleen A Cooney,
Jong Y. Park,
L. Cannon-Albright,
H. Brenner,
T. Habuchi,
Hong-wei Zhang,
Yong-jie Lu,
R. Kaneva,
K. Muir,
S. Benlloch,
D. Leongamornlert,
E. Saunders,
M. Tymrakiewicz,
N. Mahmud,
M. Guy,
L. O'Brien,
R. Wilkinson,
A. Hall,
E. Sawyer,
Tokhir Dadaev,
J. Morrison,
D. Dearnaley,
A. Horwich,
R. Huddart,
Vincent S Khoo,
Christopher C Parker,
N. V. As,
C. Woodhouse,
A. Thompson,
T. Christmas,
C. Ogden,
Colin S. Cooper,
Aritaya Lophatonanon,
M. Southey,
John L. Hopper,
D. English,
Tiina Wahlfors,
T. Tammela,
P. Klarskov,
B. Nordestgaard,
M. RΓΈder,
A. TybjΓ¦rgβHansen,
S. Bojesen,
R. Travis,
F. Canzian,
R. Kaaks,
F. Wiklund,
M. Aly,
S. Lindstrom,
W. Diver,
S. Gapstur,
M. Stern,
RomaΜn Corral,
J. Virtamo,
A. Cox,
C. Haiman,
L. Marchand,
L. FitzGerald,
S. Kolb,
E. Kwon,
D. Karyadi,
T. Γrntoft,
M. Borre,
A. Meyer,
J. Serth,
M. Yeager,
S. I. Berndt,
J. Marthick,
B. Patterson,
D. WokoΕorczyk,
J. Batra,
F. Lose,
S. McDonnell,
Amit D. Joshi,
Ahva Shahabi,
A. Rinckleb,
Ana Ray,
T. Sellers,
Hui-Yi Lin,
Robert A. Stephenson,
Jim Farnham,
H. Muller,
D. Rothenbacher,
N. Tsuchiya,
S. Narita,
G. Cao,
C. Slavov,
V. Mitev,
D. Easton,
R. Eeles
|
8 |
2011 |
8
π
|
|
π
|
Germline BRCA1 mutations increase prostate cancer risk
18 auth.
D. Leongamornlert,
N. Mahmud,
M. Tymrakiewicz,
E. Saunders,
Tokhir Dadaev,
E. Castro,
C. Goh,
K. Govindasami,
M. Guy,
L. O'Brien,
...
E. Sawyer,
A. Hall,
R. Wilkinson,
D. Easton,
D. Goldgar,
R. Eeles,
R. Eeles,
Z. Kote-Jarai
|
8 |
2012 |
8
π
|
|
π
|
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
147 auth.
Ali Amin Al Olama,
Z. Kote-Jarai,
F. Schumacher,
F. Wiklund,
S. Berndt,
S. Benlloch,
G. Giles,
G. Severi,
D. Neal,
F. Hamdy,
J. Donovan,
D. Hunter,
B. Henderson,
M. Thun,
M. Gaziano,
...
E. Giovannucci,
A. Siddiq,
R. Travis,
D. Cox,
F. Canzian,
E. Riboli,
T. Key,
G. Andriole,
D. Albanes,
R. Hayes,
J. Schleutker,
A. Auvinen,
T. Tammela,
Maren Weischer,
J. Stanford,
E. Ostrander,
C. Cybulski,
J. LubiΕski,
S. Thibodeau,
D. Schaid,
K. D. SΓΈrensen,
J. Batra,
J. Clements,
S. Chambers,
J. Aitken,
R. Gardiner,
C. Maier,
W. Vogel,
T. DΓΆrk,
H. Brenner,
T. Habuchi,
S. Ingles,
E. John,
J. Dickinson,
L. Cannon-Albright,
M. Teixeira,
R. Kaneva,
Hong-wei Zhang,
Yong-jie Lu,
Jong Y. Park,
K. Cooney,
K. Muir,
D. Leongamornlert,
E. Saunders,
M. Tymrakiewicz,
N. Mahmud,
M. Guy,
K. Govindasami,
L. O'Brien,
R. Wilkinson,
A. Hall,
E. Sawyer,
Tokhir Dadaev,
J. Morrison,
D. Dearnaley,
A. Horwich,
R. Huddart,
V. Khoo,
C. Parker,
N. Van As,
C. Woodhouse,
A. Thompson,
T. Dudderidge,
C. Ogden,
C. Cooper,
Artitaya Lophatonanon,
M. Southey,
J. Hopper,
D. English,
J. Virtamo,
L. Le Marchand,
D. Campa,
R. Kaaks,
S. Lindstrom,
W. Diver,
S. Gapstur,
M. Yeager,
A. Cox,
M. Stern,
RomaΜn Corral,
M. Aly,
W. Isaacs,
J. Adolfsson,
Jianfeng Xu,
S. Zheng,
Tiina Wahlfors,
K. Taari,
P. Kujala,
P. Klarskov,
B. Nordestgaard,
M. RΓΈder,
R. Frikke-Schmidt,
S. Bojesen,
L. FitzGerald,
S. Kolb,
E. Kwon,
D. Karyadi,
T. Orntoft,
M. Borre,
A. Rinckleb,
Manuel Luedeke,
K. Herkommer,
A. Meyer,
J. Serth,
J. Marthick,
B. Patterson,
D. WokoΕorczyk,
A. Spurdle,
F. Lose,
S. McDonnell,
A. Joshi,
Ahva Shahabi,
P. Pinto,
Joana C Santos,
Ana Ray,
T. Sellers,
Hui-Yi Lin,
R. Stephenson,
C. Teerlink,
H. Muller,
D. Rothenbacher,
N. Tsuchiya,
S. Narita,
G. Cao,
C. Slavov,
V. Mitev,
S. Chanock,
H. Gronberg,
C. Haiman,
P. Kraft,
D. Easton,
R. Eeles
|
7 |
2013 |
7
π
|
|
π
|
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
35 auth.
Z. Kote-Jarai,
A. Olama,
D. Leongamornlert,
M. Tymrakiewicz,
E. Saunders,
M. Guy,
G. Giles,
G. Giles,
G. Severi,
G. Severi,
M. Southey,
M. Southey,
J. Hopper,
K. Sit,
Jonathan M. Harris,
...
J. Batra,
A. Spurdle,
Judith A. Clements,
F. Hamdy,
D. E. Neal,
J. Donovan,
K. Muir,
P. Pharoah,
S. Chanock,
Nathan Brown,
S. Benlloch,
E. Castro,
N. Mahmud,
L. O'Brien,
A. Hall,
E. Sawyer,
R. Wilkinson,
D. Easton,
R. Eeles,
R. Eeles
|
6 |
2011 |
6
π
|
|
π
|
Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort
22 auth.
C. Goh,
E. Saunders,
D. Leongamornlert,
M. Tymrakiewicz,
K. Thomas,
E. Selvadurai,
Ruth Woode-Amissah,
Tokhir Dadaev,
N. Mahmud,
E. Castro,
...
D. Olmos,
M. Guy,
K. Govindasami,
L. O'Brien,
A. Hall,
R. Wilkinson,
E. Sawyer,
A. A. Al Olama,
D. Easton,
Z. Kote-Jarai,
C. Parker,
R. Eeles
|
5 |
2013 |
5
π
|
|
π
|
Germline BRCA 1 mutations increase prostate cancer risk
17 auth.
D. Leongamornlert,
N. Mahmud,
M. Tymrakiewicz,
E. Saunders,
T. Dadaev,
E. Castro,
C. Goh,
K. Govindasami,
M. Guy,
L. O'Brien,
...
E. Sawyer,
A. Hall,
R. Wilkinson,
D. Easton,
D. Goldgar,
R. Eeles,
Z. Kote-Jarai
|
4 |
2015 |
4
π
|
|
π
|
Correlation of germ-line BRCA2 mutations with aggressive prostate cancer and outcome.
16 auth.
E. Castro,
C. Goh,
D. Olmos,
D. Leongamornlert,
E. Saunders,
M. Tymrakiewicz,
N. Mahmud,
T. Dadaev,
K. Govindasami,
M. Guy,
...
L. OBrien,
E. Sawyer,
A. Hall,
R. Wilkinson,
Z. Kote-Jarai,
R. Eeles
|
3 |
2011 |
3
π
|
|
π
|
Abstract 4495: Clinical implications of family history of prostate cancer in an active surveillance cohort
22 auth.
C. Goh,
E. Saunders,
D. Leongamornlert,
M. Tymrakiewicz,
K. Thomas,
E. Selvadurai,
Ruth Woode-Amissah,
Tokhir Dadaev,
N. Mahmud,
E. Castro,
...
D. Olmos,
M. Guy,
K. Govindasami,
L. O'Brien,
A. Hall,
R. Wilkinson,
E. Sawyer,
A. Olama,
D. Easton,
Z. Kote-Jarai,
C. Parker,
R. Eeles
|
0 |
2012 |
0
π
|
